| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 131 | 2025 | 646 | 20.750 |
Why?
|
| Amyloid beta-Peptides | 49 | 2024 | 250 | 5.230 |
Why?
|
| tau Proteins | 38 | 2025 | 104 | 4.810 |
Why?
|
| Oxidative Stress | 42 | 2024 | 489 | 4.320 |
Why?
|
| Brain | 50 | 2024 | 2429 | 3.330 |
Why?
|
| Adaptation, Physiological | 13 | 2025 | 349 | 2.990 |
Why?
|
| Biological Evolution | 21 | 2023 | 1073 | 2.980 |
Why?
|
| Neurodegenerative Diseases | 11 | 2024 | 59 | 2.500 |
Why?
|
| Genome | 14 | 2025 | 417 | 2.470 |
Why?
|
| Evolution, Molecular | 22 | 2021 | 902 | 2.290 |
Why?
|
| Genomics | 16 | 2025 | 898 | 2.260 |
Why?
|
| Aging | 16 | 2024 | 770 | 2.240 |
Why?
|
| Lemur | 6 | 2024 | 16 | 2.070 |
Why?
|
| Genome, Human | 15 | 2021 | 832 | 2.030 |
Why?
|
| Animals | 122 | 2025 | 28910 | 1.960 |
Why?
|
| Antioxidants | 9 | 2024 | 236 | 1.930 |
Why?
|
| Genetics, Population | 13 | 2025 | 449 | 1.920 |
Why?
|
| Humans | 232 | 2025 | 97893 | 1.910 |
Why?
|
| Amyloid | 8 | 2024 | 104 | 1.880 |
Why?
|
| Primates | 6 | 2020 | 164 | 1.670 |
Why?
|
| Selection, Genetic | 9 | 2025 | 571 | 1.620 |
Why?
|
| Genetic Variation | 21 | 2025 | 1445 | 1.570 |
Why?
|
| Mitochondria | 15 | 2024 | 650 | 1.530 |
Why?
|
| Nervous System Diseases | 4 | 2024 | 169 | 1.480 |
Why?
|
| Body Size | 3 | 2021 | 103 | 1.460 |
Why?
|
| Neuroprotective Agents | 5 | 2020 | 94 | 1.450 |
Why?
|
| Oxidation-Reduction | 14 | 2020 | 419 | 1.400 |
Why?
|
| Gene Dosage | 10 | 2012 | 216 | 1.380 |
Why?
|
| Extinction, Biological | 6 | 2021 | 102 | 1.350 |
Why?
|
| Neurons | 27 | 2021 | 1619 | 1.320 |
Why?
|
| Plaque, Amyloid | 17 | 2024 | 69 | 1.290 |
Why?
|
| Pan troglodytes | 8 | 2014 | 203 | 1.230 |
Why?
|
| Thermodynamics | 5 | 2018 | 327 | 1.230 |
Why?
|
| Dementia | 5 | 2025 | 226 | 1.190 |
Why?
|
| Cognitive Dysfunction | 5 | 2025 | 208 | 1.190 |
Why?
|
| DNA, Mitochondrial | 7 | 2022 | 211 | 1.120 |
Why?
|
| Hominidae | 6 | 2017 | 110 | 1.120 |
Why?
|
| Lizards | 2 | 2025 | 30 | 1.020 |
Why?
|
| Neurofibrillary Tangles | 16 | 2024 | 49 | 1.010 |
Why?
|
| Nerve Degeneration | 6 | 2018 | 78 | 0.990 |
Why?
|
| Phenotype | 14 | 2022 | 2638 | 0.980 |
Why?
|
| Body Height | 2 | 2022 | 109 | 0.970 |
Why?
|
| Paleontology | 3 | 2015 | 85 | 0.940 |
Why?
|
| Sequence Analysis, DNA | 14 | 2021 | 911 | 0.930 |
Why?
|
| Hippocampus | 17 | 2024 | 462 | 0.890 |
Why?
|
| Neanderthals | 4 | 2017 | 24 | 0.870 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2018 | 412 | 0.870 |
Why?
|
| Introduced Species | 1 | 2025 | 18 | 0.860 |
Why?
|
| RNA | 4 | 2017 | 595 | 0.860 |
Why?
|
| Stem Cell Transplantation | 2 | 2024 | 194 | 0.860 |
Why?
|
| Agriculture | 3 | 2022 | 46 | 0.840 |
Why?
|
| DNA | 9 | 2021 | 1274 | 0.840 |
Why?
|
| DNA, Ancient | 2 | 2022 | 22 | 0.840 |
Why?
|
| Tauopathies | 3 | 2022 | 17 | 0.840 |
Why?
|
| Peptide Fragments | 6 | 2017 | 479 | 0.830 |
Why?
|
| Farmers | 4 | 2022 | 10 | 0.820 |
Why?
|
| Metals | 2 | 2020 | 104 | 0.820 |
Why?
|
| Ants | 1 | 2025 | 59 | 0.790 |
Why?
|
| Genome, Mitochondrial | 2 | 2021 | 34 | 0.790 |
Why?
|
| alpha-Synuclein | 7 | 2024 | 28 | 0.770 |
Why?
|
| Iron | 9 | 2024 | 178 | 0.770 |
Why?
|
| Parkinson Disease | 7 | 2017 | 186 | 0.750 |
Why?
|
| Encephalitis | 1 | 2023 | 45 | 0.740 |
Why?
|
| Diabetic Retinopathy | 1 | 2023 | 81 | 0.740 |
Why?
|
| Retina | 2 | 2024 | 221 | 0.720 |
Why?
|
| Skeleton | 1 | 2022 | 28 | 0.710 |
Why?
|
| Health | 1 | 2022 | 27 | 0.710 |
Why?
|
| Phylogeny | 12 | 2021 | 1339 | 0.690 |
Why?
|
| Vaccines | 1 | 2023 | 86 | 0.690 |
Why?
|
| Interdisciplinary Research | 1 | 2021 | 8 | 0.690 |
Why?
|
| Somatotypes | 1 | 2021 | 4 | 0.680 |
Why?
|
| Neurology | 2 | 2024 | 84 | 0.680 |
Why?
|
| Anthropology, Physical | 1 | 2021 | 15 | 0.670 |
Why?
|
| Gastropoda | 1 | 2021 | 4 | 0.670 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 358 | 0.670 |
Why?
|
| Multimodal Imaging | 1 | 2022 | 115 | 0.660 |
Why?
|
| Apolipoproteins E | 2 | 2024 | 139 | 0.650 |
Why?
|
| Microsatellite Repeats | 2 | 2019 | 150 | 0.650 |
Why?
|
| Strepsirhini | 2 | 2017 | 7 | 0.650 |
Why?
|
| Disease Models, Animal | 14 | 2025 | 2572 | 0.650 |
Why?
|
| Writing | 1 | 2020 | 27 | 0.640 |
Why?
|
| Biomedical Research | 3 | 2022 | 470 | 0.640 |
Why?
|
| Urban Renewal | 1 | 2020 | 2 | 0.630 |
Why?
|
| Clinical Trials as Topic | 3 | 2023 | 1125 | 0.630 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2020 | 62 | 0.620 |
Why?
|
| Genetic Markers | 3 | 2017 | 471 | 0.620 |
Why?
|
| Neurotransmitter Agents | 1 | 2020 | 102 | 0.610 |
Why?
|
| Fossils | 4 | 2017 | 414 | 0.610 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2018 | 148 | 0.610 |
Why?
|
| Publishing | 1 | 2020 | 97 | 0.600 |
Why?
|
| Lewy Body Disease | 5 | 2023 | 15 | 0.600 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2019 | 132 | 0.590 |
Why?
|
| Aquaporin 3 | 1 | 2019 | 2 | 0.580 |
Why?
|
| RNA, Transfer | 2 | 2018 | 176 | 0.570 |
Why?
|
| Hormones | 3 | 2018 | 138 | 0.570 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 61 | 0.570 |
Why?
|
| Immunologic Factors | 1 | 2020 | 179 | 0.570 |
Why?
|
| Apolipoprotein E4 | 4 | 2018 | 34 | 0.570 |
Why?
|
| Glycerol | 1 | 2019 | 35 | 0.570 |
Why?
|
| Cell Nucleus | 4 | 2021 | 615 | 0.570 |
Why?
|
| Tubulin | 1 | 2018 | 61 | 0.560 |
Why?
|
| Brain Injuries | 2 | 2019 | 142 | 0.560 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2018 | 4 | 0.560 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2023 | 2558 | 0.550 |
Why?
|
| Energy Metabolism | 3 | 2018 | 315 | 0.550 |
Why?
|
| Prion Diseases | 4 | 2010 | 31 | 0.550 |
Why?
|
| Aged | 41 | 2025 | 21701 | 0.550 |
Why?
|
| Protein Biosynthesis | 2 | 2018 | 393 | 0.540 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 2018 | 20 | 0.540 |
Why?
|
| Species Specificity | 11 | 2020 | 690 | 0.540 |
Why?
|
| Entorhinal Cortex | 1 | 2018 | 16 | 0.540 |
Why?
|
| Genetic Therapy | 1 | 2020 | 373 | 0.530 |
Why?
|
| Xylose | 1 | 2017 | 10 | 0.530 |
Why?
|
| Base Sequence | 9 | 2021 | 2222 | 0.530 |
Why?
|
| Sex Factors | 1 | 2021 | 1137 | 0.530 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 358 | 0.530 |
Why?
|
| Tool Use Behavior | 1 | 2017 | 14 | 0.520 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 569 | 0.520 |
Why?
|
| Olfactory Bulb | 1 | 2018 | 41 | 0.520 |
Why?
|
| Aged, 80 and over | 29 | 2025 | 7386 | 0.520 |
Why?
|
| Echolocation | 1 | 2017 | 6 | 0.520 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2017 | 7 | 0.520 |
Why?
|
| Color Vision | 3 | 2017 | 17 | 0.520 |
Why?
|
| Plant Extracts | 1 | 2019 | 252 | 0.510 |
Why?
|
| Anodontia | 1 | 2017 | 3 | 0.510 |
Why?
|
| Lipid Bilayers | 1 | 2018 | 148 | 0.510 |
Why?
|
| Cognition | 6 | 2023 | 669 | 0.510 |
Why?
|
| Molar, Third | 1 | 2017 | 6 | 0.510 |
Why?
|
| Tooth, Impacted | 1 | 2017 | 7 | 0.510 |
Why?
|
| Nucleic Acids | 2 | 2016 | 36 | 0.510 |
Why?
|
| Body Fluids | 1 | 2017 | 35 | 0.510 |
Why?
|
| Archaeology | 1 | 2017 | 18 | 0.510 |
Why?
|
| Boxing | 1 | 2017 | 1 | 0.510 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 72 | 0.500 |
Why?
|
| Sodium Chloride | 1 | 2017 | 83 | 0.500 |
Why?
|
| Symporters | 1 | 2017 | 116 | 0.500 |
Why?
|
| Indians, North American | 1 | 2017 | 49 | 0.500 |
Why?
|
| Behavior, Animal | 1 | 2020 | 398 | 0.490 |
Why?
|
| Nanotechnology | 1 | 2017 | 74 | 0.490 |
Why?
|
| Rod Opsins | 4 | 2017 | 11 | 0.490 |
Why?
|
| Hepcidins | 1 | 2016 | 5 | 0.490 |
Why?
|
| Guanosine | 5 | 2017 | 31 | 0.480 |
Why?
|
| Iron Overload | 1 | 2016 | 8 | 0.480 |
Why?
|
| Ferrosoferric Oxide | 1 | 2016 | 19 | 0.480 |
Why?
|
| Escherichia coli Proteins | 1 | 2017 | 185 | 0.480 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 198 | 0.470 |
Why?
|
| Cucurbita | 1 | 2015 | 1 | 0.470 |
Why?
|
| Molecular Dynamics Simulation | 7 | 2018 | 325 | 0.470 |
Why?
|
| Mice, Transgenic | 9 | 2025 | 1605 | 0.470 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 1850 | 0.470 |
Why?
|
| Cation Transport Proteins | 1 | 2016 | 65 | 0.460 |
Why?
|
| Glucose | 2 | 2018 | 704 | 0.460 |
Why?
|
| Antibodies, Monoclonal, Humanized | 5 | 2024 | 1098 | 0.450 |
Why?
|
| Amyloidosis | 4 | 2024 | 136 | 0.450 |
Why?
|
| Lipid Peroxidation | 3 | 2011 | 46 | 0.440 |
Why?
|
| Ecology | 1 | 2015 | 84 | 0.440 |
Why?
|
| Endothelin-1 | 1 | 2015 | 42 | 0.440 |
Why?
|
| Leptin | 1 | 2015 | 101 | 0.430 |
Why?
|
| Madagascar | 7 | 2024 | 40 | 0.430 |
Why?
|
| Glucagon-Like Peptides | 2 | 2025 | 24 | 0.430 |
Why?
|
| Nanoparticles | 1 | 2017 | 218 | 0.430 |
Why?
|
| Phytotherapy | 1 | 2015 | 139 | 0.420 |
Why?
|
| Plasmodium falciparum | 2 | 2016 | 57 | 0.420 |
Why?
|
| Growth Disorders | 1 | 2014 | 64 | 0.420 |
Why?
|
| Cytokines | 2 | 2018 | 889 | 0.420 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 2896 | 0.410 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2021 | 660 | 0.410 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 118 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2025 | 1286 | 0.400 |
Why?
|
| Pathology | 2 | 2011 | 36 | 0.400 |
Why?
|
| Phosphorylation | 12 | 2025 | 1145 | 0.400 |
Why?
|
| Immunohistochemistry | 16 | 2019 | 1815 | 0.400 |
Why?
|
| Chronic Disease | 2 | 2017 | 985 | 0.400 |
Why?
|
| Particulate Matter | 1 | 2015 | 138 | 0.400 |
Why?
|
| Aldehydes | 2 | 2011 | 21 | 0.390 |
Why?
|
| Drug Design | 2 | 2024 | 135 | 0.390 |
Why?
|
| Bacteria | 1 | 2018 | 545 | 0.390 |
Why?
|
| Darkness | 2 | 2017 | 47 | 0.380 |
Why?
|
| Stroke | 1 | 2023 | 1154 | 0.380 |
Why?
|
| Male | 45 | 2025 | 46995 | 0.380 |
Why?
|
| Biomarkers | 10 | 2023 | 2016 | 0.380 |
Why?
|
| Erythrocytes | 1 | 2013 | 242 | 0.370 |
Why?
|
| Mitochondrial Dynamics | 3 | 2024 | 61 | 0.360 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2012 | 14 | 0.360 |
Why?
|
| Dementia, Vascular | 1 | 2012 | 7 | 0.360 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2012 | 16 | 0.360 |
Why?
|
| Disease Progression | 7 | 2025 | 1609 | 0.360 |
Why?
|
| Histocytochemistry | 1 | 2012 | 122 | 0.350 |
Why?
|
| Feeding Behavior | 1 | 2015 | 350 | 0.350 |
Why?
|
| Hypoglycemic Agents | 2 | 2025 | 412 | 0.350 |
Why?
|
| Lemuridae | 2 | 2024 | 6 | 0.350 |
Why?
|
| Models, Neurological | 2 | 2012 | 411 | 0.330 |
Why?
|
| DNA Repair | 1 | 2012 | 363 | 0.320 |
Why?
|
| DNA Damage | 1 | 2012 | 399 | 0.320 |
Why?
|
| Mice | 18 | 2025 | 12707 | 0.310 |
Why?
|
| Gene Expression Regulation | 8 | 2018 | 2023 | 0.310 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 271 | 0.310 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2009 | 11 | 0.310 |
Why?
|
| Pyramidal Cells | 5 | 2018 | 84 | 0.310 |
Why?
|
| Diet | 5 | 2023 | 468 | 0.310 |
Why?
|
| History, Ancient | 2 | 2022 | 84 | 0.300 |
Why?
|
| Microglia | 4 | 2024 | 131 | 0.300 |
Why?
|
| Female | 38 | 2025 | 51463 | 0.300 |
Why?
|
| Adaptation, Biological | 2 | 2021 | 89 | 0.300 |
Why?
|
| Chronic Traumatic Encephalopathy | 2 | 2019 | 6 | 0.300 |
Why?
|
| Forests | 4 | 2021 | 32 | 0.290 |
Why?
|
| Geography | 3 | 2017 | 249 | 0.290 |
Why?
|
| Ecosystem | 5 | 2025 | 424 | 0.290 |
Why?
|
| History, 21st Century | 4 | 2014 | 196 | 0.280 |
Why?
|
| Feces | 1 | 2010 | 387 | 0.280 |
Why?
|
| Models, Genetic | 5 | 2017 | 1005 | 0.280 |
Why?
|
| Sequence Alignment | 5 | 2018 | 353 | 0.270 |
Why?
|
| Amyloidogenic Proteins | 3 | 2023 | 21 | 0.270 |
Why?
|
| Obesity | 1 | 2015 | 1060 | 0.270 |
Why?
|
| Tandem Repeat Sequences | 1 | 2008 | 31 | 0.270 |
Why?
|
| History, 20th Century | 4 | 2014 | 323 | 0.270 |
Why?
|
| Disaster Planning | 2 | 2008 | 24 | 0.270 |
Why?
|
| Gene Flow | 2 | 2019 | 107 | 0.270 |
Why?
|
| alpha-Amylases | 1 | 2007 | 2 | 0.270 |
Why?
|
| Trust | 2 | 2021 | 106 | 0.270 |
Why?
|
| Systems Biology | 2 | 2021 | 51 | 0.260 |
Why?
|
| Rainforest | 7 | 2023 | 18 | 0.250 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 295 | 0.250 |
Why?
|
| Cerebral Cortex | 3 | 2025 | 571 | 0.250 |
Why?
|
| Membrane Proteins | 5 | 2017 | 1285 | 0.250 |
Why?
|
| Haplotypes | 2 | 2021 | 657 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 6 | 2012 | 512 | 0.250 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 27 | 0.250 |
Why?
|
| Protein Binding | 4 | 2018 | 1555 | 0.240 |
Why?
|
| United States | 10 | 2025 | 8183 | 0.240 |
Why?
|
| Binding Sites | 3 | 2018 | 1159 | 0.240 |
Why?
|
| Independent Living | 1 | 2016 | 33 | 0.240 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 235 | 0.240 |
Why?
|
| Middle Aged | 29 | 2025 | 29352 | 0.240 |
Why?
|
| Copper | 2 | 2004 | 81 | 0.240 |
Why?
|
| PAX9 Transcription Factor | 1 | 2005 | 2 | 0.240 |
Why?
|
| MSX1 Transcription Factor | 1 | 2005 | 3 | 0.240 |
Why?
|
| Color Perception | 1 | 2007 | 123 | 0.230 |
Why?
|
| Gene Deletion | 1 | 2007 | 353 | 0.230 |
Why?
|
| Transcriptome | 1 | 2011 | 820 | 0.230 |
Why?
|
| Rodent Diseases | 1 | 2025 | 35 | 0.230 |
Why?
|
| Protein Multimerization | 2 | 2017 | 194 | 0.220 |
Why?
|
| Zoonoses | 1 | 2025 | 29 | 0.220 |
Why?
|
| Brain Waves | 1 | 2025 | 33 | 0.220 |
Why?
|
| Rodentia | 1 | 2025 | 49 | 0.220 |
Why?
|
| Temporal Lobe | 2 | 2024 | 188 | 0.220 |
Why?
|
| Kinetics | 2 | 2017 | 1477 | 0.220 |
Why?
|
| Social Environment | 1 | 2016 | 199 | 0.220 |
Why?
|
| Endangered Species | 2 | 2017 | 27 | 0.220 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2017 | 48 | 0.220 |
Why?
|
| Rhodanine | 1 | 2024 | 1 | 0.220 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2016 | 76 | 0.220 |
Why?
|
| Thiourea | 1 | 2024 | 10 | 0.220 |
Why?
|
| Community Health Services | 1 | 2016 | 81 | 0.220 |
Why?
|
| Urea | 1 | 2024 | 54 | 0.220 |
Why?
|
| GTP Phosphohydrolases | 2 | 2018 | 83 | 0.210 |
Why?
|
| Influenza, Human | 2 | 2008 | 357 | 0.210 |
Why?
|
| Fluorescent Dyes | 2 | 2024 | 257 | 0.210 |
Why?
|
| Global Health | 2 | 2024 | 215 | 0.210 |
Why?
|
| Social Support | 1 | 2016 | 246 | 0.210 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 117 | 0.210 |
Why?
|
| Cell Cycle | 3 | 2019 | 518 | 0.200 |
Why?
|
| Life Style | 3 | 2019 | 193 | 0.200 |
Why?
|
| Olfactory Mucosa | 1 | 2003 | 33 | 0.200 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 31 | 0.200 |
Why?
|
| Microtubules | 2 | 2004 | 141 | 0.200 |
Why?
|
| Mitochondrial Membranes | 1 | 2023 | 22 | 0.200 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 200 | 0.190 |
Why?
|
| beta-Defensins | 2 | 2013 | 12 | 0.190 |
Why?
|
| Neural Stem Cells | 1 | 2024 | 73 | 0.190 |
Why?
|
| Russia | 1 | 2023 | 29 | 0.190 |
Why?
|
| Research Design | 4 | 2021 | 650 | 0.190 |
Why?
|
| Gene Editing | 1 | 2023 | 56 | 0.190 |
Why?
|
| Edema | 1 | 2023 | 68 | 0.190 |
Why?
|
| Mortality | 1 | 2024 | 158 | 0.190 |
Why?
|
| Reactive Oxygen Species | 5 | 2012 | 525 | 0.180 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2024 | 154 | 0.180 |
Why?
|
| Paleopathology | 1 | 2022 | 6 | 0.180 |
Why?
|
| Supranuclear Palsy, Progressive | 2 | 2021 | 29 | 0.180 |
Why?
|
| Uganda | 3 | 2019 | 52 | 0.180 |
Why?
|
| Immunotherapy | 3 | 2023 | 821 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2013 | 700 | 0.180 |
Why?
|
| Arabidopsis | 1 | 2025 | 331 | 0.180 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 17 | 0.180 |
Why?
|
| Gallium | 1 | 2021 | 4 | 0.180 |
Why?
|
| Neuroglia | 2 | 2021 | 78 | 0.180 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 132 | 0.170 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1995 | 0.170 |
Why?
|
| Adult | 15 | 2022 | 29453 | 0.170 |
Why?
|
| Electrons | 1 | 2021 | 52 | 0.170 |
Why?
|
| Chromosome Mapping | 4 | 2021 | 1061 | 0.170 |
Why?
|
| Nerve Net | 1 | 2025 | 401 | 0.170 |
Why?
|
| Panama | 1 | 2021 | 7 | 0.170 |
Why?
|
| RNA, Messenger | 6 | 2018 | 2063 | 0.170 |
Why?
|
| Caribbean Region | 1 | 2021 | 28 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 1565 | 0.170 |
Why?
|
| Europe | 1 | 2022 | 356 | 0.170 |
Why?
|
| Growth Hormone | 2 | 2018 | 96 | 0.170 |
Why?
|
| Community Participation | 1 | 2021 | 40 | 0.170 |
Why?
|
| DNA Fingerprinting | 2 | 2019 | 17 | 0.170 |
Why?
|
| Brain Chemistry | 5 | 2008 | 110 | 0.170 |
Why?
|
| Cebus | 1 | 2021 | 19 | 0.170 |
Why?
|
| Publications | 1 | 2021 | 32 | 0.160 |
Why?
|
| Metabolomics | 3 | 2021 | 106 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2024 | 234 | 0.160 |
Why?
|
| Poverty | 2 | 2016 | 214 | 0.160 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2020 | 9 | 0.160 |
Why?
|
| Macaca mulatta | 3 | 2014 | 466 | 0.160 |
Why?
|
| Disease Outbreaks | 2 | 2008 | 148 | 0.160 |
Why?
|
| Longevity | 1 | 2021 | 64 | 0.160 |
Why?
|
| Lactoferrin | 1 | 2020 | 10 | 0.160 |
Why?
|
| Cultural Diversity | 1 | 2021 | 64 | 0.160 |
Why?
|
| Genome, Plant | 2 | 2025 | 107 | 0.160 |
Why?
|
| Salivary Glands | 1 | 2020 | 20 | 0.160 |
Why?
|
| Astrocytes | 4 | 2024 | 142 | 0.160 |
Why?
|
| Mentoring | 1 | 2021 | 40 | 0.160 |
Why?
|
| Neuroblastoma | 3 | 2019 | 409 | 0.160 |
Why?
|
| Social Media | 1 | 2022 | 119 | 0.160 |
Why?
|
| Metagenomics | 1 | 2021 | 106 | 0.160 |
Why?
|
| Genotype | 4 | 2013 | 1888 | 0.160 |
Why?
|
| Liver | 3 | 2015 | 1231 | 0.160 |
Why?
|
| Biological Products | 1 | 2022 | 189 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 301 | 0.150 |
Why?
|
| Molecular Docking Simulation | 2 | 2017 | 59 | 0.150 |
Why?
|
| Minority Groups | 1 | 2021 | 156 | 0.150 |
Why?
|
| DNA Degradation, Necrotic | 1 | 2019 | 1 | 0.150 |
Why?
|
| Ginkgo biloba | 1 | 2019 | 7 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 566 | 0.150 |
Why?
|
| Horses | 1 | 2019 | 35 | 0.150 |
Why?
|
| Child | 4 | 2022 | 7680 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 5 | 0.150 |
Why?
|
| Forensic Pathology | 1 | 2019 | 4 | 0.150 |
Why?
|
| Lithium Chloride | 1 | 2019 | 4 | 0.150 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2015 | 45 | 0.140 |
Why?
|
| Antimanic Agents | 1 | 2019 | 14 | 0.140 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 190 | 0.140 |
Why?
|
| Inflammation | 2 | 2024 | 1120 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2018 | 2007 | 0.140 |
Why?
|
| Acetylglucosamine | 1 | 2018 | 18 | 0.140 |
Why?
|
| Water | 3 | 2016 | 309 | 0.140 |
Why?
|
| Symbiosis | 1 | 2020 | 130 | 0.140 |
Why?
|
| Polymorphism, Genetic | 3 | 2017 | 831 | 0.140 |
Why?
|
| Cholesterol | 2 | 2011 | 373 | 0.140 |
Why?
|
| Calcium Compounds | 1 | 2018 | 2 | 0.140 |
Why?
|
| Microscopy, Electron | 2 | 2013 | 435 | 0.140 |
Why?
|
| Post-Concussion Syndrome | 1 | 2019 | 24 | 0.140 |
Why?
|
| Facilitated Diffusion | 1 | 2018 | 2 | 0.140 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 121 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 802 | 0.140 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2018 | 1 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 213 | 0.140 |
Why?
|
| Mutation | 5 | 2018 | 4396 | 0.140 |
Why?
|
| Tryptamines | 1 | 2018 | 2 | 0.140 |
Why?
|
| Protein Aggregates | 3 | 2024 | 28 | 0.140 |
Why?
|
| Chorion | 1 | 2018 | 15 | 0.140 |
Why?
|
| Cholinergic Neurons | 1 | 2018 | 14 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2023 | 2555 | 0.140 |
Why?
|
| Butyrylcholinesterase | 1 | 2018 | 12 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 190 | 0.140 |
Why?
|
| Acetylcholinesterase | 1 | 2018 | 42 | 0.130 |
Why?
|
| Prions | 2 | 2010 | 53 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 103 | 0.130 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 8 | 0.130 |
Why?
|
| Environment | 2 | 2017 | 233 | 0.130 |
Why?
|
| Shellfish | 1 | 2017 | 5 | 0.130 |
Why?
|
| Thailand | 1 | 2017 | 69 | 0.130 |
Why?
|
| Theta Rhythm | 1 | 2018 | 44 | 0.130 |
Why?
|
| Pandemics | 1 | 2024 | 913 | 0.130 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 111 | 0.130 |
Why?
|
| Dolphins | 1 | 2017 | 3 | 0.130 |
Why?
|
| Gene Expression | 3 | 2018 | 1320 | 0.130 |
Why?
|
| Brain Concussion | 1 | 2019 | 88 | 0.130 |
Why?
|
| Tarsiidae | 1 | 2017 | 1 | 0.130 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2018 | 100 | 0.130 |
Why?
|
| Lactase | 1 | 2017 | 6 | 0.130 |
Why?
|
| Anthropology | 1 | 2017 | 9 | 0.130 |
Why?
|
| Sympatry | 1 | 2017 | 13 | 0.130 |
Why?
|
| New Mexico | 1 | 2017 | 3 | 0.130 |
Why?
|
| Burial | 1 | 2017 | 3 | 0.130 |
Why?
|
| Exome | 1 | 2018 | 145 | 0.130 |
Why?
|
| Protein Conformation | 2 | 2017 | 925 | 0.130 |
Why?
|
| Eye | 1 | 2018 | 112 | 0.130 |
Why?
|
| Drug Stability | 1 | 2017 | 48 | 0.130 |
Why?
|
| Radiometric Dating | 1 | 2017 | 6 | 0.130 |
Why?
|
| Facial Bones | 1 | 2017 | 36 | 0.130 |
Why?
|
| Republic of Korea | 1 | 2017 | 41 | 0.130 |
Why?
|
| Anthocyanins | 1 | 2017 | 4 | 0.130 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2017 | 6 | 0.130 |
Why?
|
| Positron-Emission Tomography | 3 | 2025 | 354 | 0.130 |
Why?
|
| Spatial Learning | 1 | 2017 | 6 | 0.130 |
Why?
|
| Biomimetic Materials | 1 | 2017 | 24 | 0.130 |
Why?
|
| Communication | 1 | 2020 | 455 | 0.130 |
Why?
|
| Chitin | 2 | 2007 | 10 | 0.130 |
Why?
|
| Precision Medicine | 2 | 2021 | 498 | 0.120 |
Why?
|
| Hypoxia | 1 | 2022 | 681 | 0.120 |
Why?
|
| Selenoproteins | 1 | 2017 | 22 | 0.120 |
Why?
|
| Receptors, Nicotinic | 1 | 2018 | 133 | 0.120 |
Why?
|
| DNA Primers | 2 | 2008 | 530 | 0.120 |
Why?
|
| Ribosomes | 1 | 2017 | 106 | 0.120 |
Why?
|
| Choroid Plexus | 2 | 2013 | 16 | 0.120 |
Why?
|
| Cell Line | 4 | 2018 | 2483 | 0.120 |
Why?
|
| DNA Transposable Elements | 1 | 2017 | 170 | 0.120 |
Why?
|
| Neuritis | 1 | 2016 | 7 | 0.120 |
Why?
|
| Japan | 1 | 2017 | 303 | 0.120 |
Why?
|
| Social Justice | 1 | 2007 | 62 | 0.120 |
Why?
|
| Brain Stem | 2 | 2011 | 167 | 0.120 |
Why?
|
| Military Personnel | 1 | 2019 | 121 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 26 | 0.120 |
Why?
|
| Holography | 1 | 2016 | 3 | 0.120 |
Why?
|
| Seed Dispersal | 1 | 2016 | 3 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 321 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 98 | 0.120 |
Why?
|
| Baltimore | 2 | 2016 | 42 | 0.120 |
Why?
|
| Models, Chemical | 1 | 2017 | 185 | 0.120 |
Why?
|
| Mass Screening | 1 | 2022 | 745 | 0.120 |
Why?
|
| Chiroptera | 1 | 2017 | 59 | 0.120 |
Why?
|
| Probability | 1 | 2017 | 356 | 0.120 |
Why?
|
| HIV Infections | 1 | 2016 | 1018 | 0.120 |
Why?
|
| Aquaporins | 1 | 2016 | 14 | 0.120 |
Why?
|
| Opsins | 1 | 2016 | 13 | 0.120 |
Why?
|
| Plastids | 1 | 2015 | 10 | 0.120 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 119 | 0.120 |
Why?
|
| Propylene Glycols | 1 | 2016 | 30 | 0.120 |
Why?
|
| Time Factors | 4 | 2018 | 5555 | 0.120 |
Why?
|
| Genetic Loci | 1 | 2017 | 263 | 0.120 |
Why?
|
| Trees | 1 | 2016 | 48 | 0.120 |
Why?
|
| Risk Factors | 6 | 2025 | 6224 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 176 | 0.110 |
Why?
|
| Heart | 1 | 2018 | 527 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 249 | 0.110 |
Why?
|
| Optical Imaging | 1 | 2016 | 55 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2017 | 238 | 0.110 |
Why?
|
| Mammoths | 1 | 2015 | 1 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 110 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 83 | 0.110 |
Why?
|
| Genetic Speciation | 1 | 2017 | 127 | 0.110 |
Why?
|
| Brain Injury, Chronic | 1 | 2015 | 9 | 0.110 |
Why?
|
| Language | 1 | 2017 | 164 | 0.110 |
Why?
|
| Axons | 1 | 2016 | 181 | 0.110 |
Why?
|
| Stem Cells | 1 | 2018 | 396 | 0.110 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2015 | 13 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2019 | 417 | 0.110 |
Why?
|
| Mexico | 1 | 2015 | 75 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2017 | 225 | 0.110 |
Why?
|
| Leuprolide | 1 | 2015 | 34 | 0.110 |
Why?
|
| Nootropic Agents | 1 | 2015 | 13 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 186 | 0.110 |
Why?
|
| Mitochondrial Proteins | 2 | 2017 | 131 | 0.110 |
Why?
|
| Chlamydia Infections | 1 | 2015 | 30 | 0.110 |
Why?
|
| Pedigree | 1 | 2017 | 980 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2016 | 74 | 0.110 |
Why?
|
| Mast Cells | 1 | 2015 | 97 | 0.110 |
Why?
|
| Duffy Blood-Group System | 1 | 2014 | 8 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2017 | 572 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2018 | 2855 | 0.110 |
Why?
|
| Myosin Heavy Chains | 1 | 2015 | 92 | 0.100 |
Why?
|
| Action Potentials | 1 | 2018 | 611 | 0.100 |
Why?
|
| Medicare | 1 | 2018 | 467 | 0.100 |
Why?
|
| Residence Characteristics | 2 | 2016 | 224 | 0.100 |
Why?
|
| Chemokines | 1 | 2014 | 79 | 0.100 |
Why?
|
| Apolipoprotein E3 | 1 | 2013 | 7 | 0.100 |
Why?
|
| Physicians | 1 | 2021 | 685 | 0.100 |
Why?
|
| Body Weight | 1 | 2015 | 455 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 201 | 0.100 |
Why?
|
| Synapses | 2 | 2023 | 280 | 0.100 |
Why?
|
| Texas | 1 | 2014 | 135 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 2892 | 0.100 |
Why?
|
| Adolescent | 4 | 2015 | 10078 | 0.100 |
Why?
|
| Models, Biological | 3 | 2016 | 1806 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1394 | 0.100 |
Why?
|
| Autopsy | 3 | 2019 | 131 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 291 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 239 | 0.100 |
Why?
|
| Platyrrhini | 1 | 2012 | 3 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 169 | 0.090 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 28 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2008 | 195 | 0.090 |
Why?
|
| Pseudogenes | 1 | 2012 | 39 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 12 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 604 | 0.090 |
Why?
|
| Gene Frequency | 1 | 2014 | 715 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2016 | 600 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 539 | 0.090 |
Why?
|
| Africa | 2 | 2025 | 112 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 70 | 0.090 |
Why?
|
| Lipofuscin | 1 | 2011 | 2 | 0.090 |
Why?
|
| Neuroimaging | 3 | 2020 | 143 | 0.090 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2011 | 28 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2012 | 299 | 0.090 |
Why?
|
| Ribosomal Protein S6 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Neurobiology | 1 | 2011 | 11 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 99 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 548 | 0.090 |
Why?
|
| Hospitalization | 1 | 2018 | 982 | 0.090 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2022 | 56 | 0.090 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2011 | 9 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 337 | 0.090 |
Why?
|
| Open Reading Frames | 1 | 2011 | 118 | 0.090 |
Why?
|
| Nucleotides | 1 | 2011 | 93 | 0.090 |
Why?
|
| Cytoplasmic Granules | 1 | 2011 | 97 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 142 | 0.080 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 68 | 0.080 |
Why?
|
| Lewy Bodies | 2 | 2010 | 3 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 453 | 0.080 |
Why?
|
| Acclimatization | 2 | 2023 | 91 | 0.080 |
Why?
|
| Dogs | 1 | 2011 | 639 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2014 | 383 | 0.080 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2010 | 27 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2015 | 334 | 0.080 |
Why?
|
| CD3 Complex | 1 | 2010 | 137 | 0.080 |
Why?
|
| Internet | 1 | 2013 | 358 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 99 | 0.080 |
Why?
|
| Paraffin Embedding | 1 | 2010 | 77 | 0.080 |
Why?
|
| Computer Simulation | 4 | 2016 | 1145 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 894 | 0.080 |
Why?
|
| Exercise | 1 | 2013 | 380 | 0.080 |
Why?
|
| Microbiota | 1 | 2016 | 467 | 0.080 |
Why?
|
| Kynurenine | 1 | 2010 | 25 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2010 | 274 | 0.080 |
Why?
|
| Rats | 4 | 2022 | 4071 | 0.080 |
Why?
|
| Transfection | 3 | 2018 | 883 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2010 | 667 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2009 | 13 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2009 | 4 | 0.070 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 68 | 0.070 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2009 | 35 | 0.070 |
Why?
|
| S Phase | 1 | 2009 | 64 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2023 | 1416 | 0.070 |
Why?
|
| Growth | 1 | 2009 | 42 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2024 | 305 | 0.070 |
Why?
|
| Genes, myc | 1 | 2009 | 38 | 0.070 |
Why?
|
| Neocortex | 3 | 2006 | 100 | 0.070 |
Why?
|
| Hypoxia, Brain | 1 | 2009 | 41 | 0.070 |
Why?
|
| Brain Neoplasms | 2 | 2006 | 839 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 40 | 0.070 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 59 | 0.070 |
Why?
|
| Alleles | 1 | 2012 | 1160 | 0.070 |
Why?
|
| Acetylcarnitine | 1 | 2008 | 1 | 0.070 |
Why?
|
| Thioctic Acid | 1 | 2008 | 2 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 69 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 155 | 0.070 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2008 | 1 | 0.070 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 8 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2019 | 9682 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 3202 | 0.070 |
Why?
|
| Starch | 1 | 2007 | 9 | 0.070 |
Why?
|
| Homeostasis | 1 | 2010 | 474 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 3340 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 369 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 731 | 0.060 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 32 | 0.060 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2007 | 4 | 0.060 |
Why?
|
| Antigens | 1 | 2008 | 225 | 0.060 |
Why?
|
| Polysaccharides | 1 | 2007 | 99 | 0.060 |
Why?
|
| Pan paniscus | 1 | 2007 | 10 | 0.060 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2006 | 7 | 0.060 |
Why?
|
| Cell Death | 3 | 2018 | 257 | 0.060 |
Why?
|
| Gorilla gorilla | 1 | 2007 | 46 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2024 | 1946 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2021 | 720 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2007 | 118 | 0.060 |
Why?
|
| Antibodies | 1 | 2008 | 349 | 0.060 |
Why?
|
| Lipid Metabolism | 2 | 2024 | 221 | 0.060 |
Why?
|
| Synteny | 2 | 2021 | 31 | 0.060 |
Why?
|
| Family | 1 | 2008 | 327 | 0.060 |
Why?
|
| Geographic Information Systems | 1 | 2016 | 29 | 0.060 |
Why?
|
| Needle-Exchange Programs | 1 | 2016 | 22 | 0.060 |
Why?
|
| Africa, Central | 2 | 2017 | 6 | 0.060 |
Why?
|
| Social Isolation | 1 | 2016 | 73 | 0.060 |
Why?
|
| Health Priorities | 1 | 2016 | 30 | 0.060 |
Why?
|
| Urban Health | 1 | 2016 | 54 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2005 | 14 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 419 | 0.060 |
Why?
|
| Museums | 1 | 2025 | 17 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1254 | 0.060 |
Why?
|
| Glycation End Products, Advanced | 1 | 2005 | 12 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 92 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 214 | 0.060 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2025 | 65 | 0.060 |
Why?
|
| Likelihood Functions | 1 | 2005 | 258 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2006 | 286 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2016 | 386 | 0.050 |
Why?
|
| Sensation Disorders | 1 | 2024 | 33 | 0.050 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2004 | 7 | 0.050 |
Why?
|
| Urban Population | 1 | 2016 | 246 | 0.050 |
Why?
|
| Cyclin B | 1 | 2004 | 16 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 424 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2004 | 92 | 0.050 |
Why?
|
| Cyclins | 1 | 2004 | 80 | 0.050 |
Why?
|
| Lysine | 1 | 2005 | 181 | 0.050 |
Why?
|
| Young Adult | 5 | 2019 | 7504 | 0.050 |
Why?
|
| Glioma | 1 | 2006 | 309 | 0.050 |
Why?
|
| Endocrine System Diseases | 1 | 2024 | 26 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 425 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2003 | 23 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 750 | 0.050 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2003 | 46 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2016 | 968 | 0.050 |
Why?
|
| Electron Transport Complex IV | 1 | 2003 | 48 | 0.050 |
Why?
|
| Hydroxyl Radical | 1 | 2003 | 38 | 0.050 |
Why?
|
| Dietary Supplements | 2 | 2018 | 152 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2023 | 42 | 0.050 |
Why?
|
| Deoxyribonucleases | 1 | 2002 | 27 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 62 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2020 | 481 | 0.050 |
Why?
|
| Biological Transport, Active | 2 | 2016 | 98 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 53 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2002 | 16 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2023 | 303 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 225 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2023 | 152 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2003 | 79 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 17 | 0.050 |
Why?
|
| Lactates | 1 | 2022 | 34 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2002 | 89 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 29 | 0.050 |
Why?
|
| Streptozocin | 1 | 2022 | 57 | 0.050 |
Why?
|
| Multiple System Atrophy | 1 | 2002 | 6 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3606 | 0.040 |
Why?
|
| Glutamates | 1 | 2022 | 84 | 0.040 |
Why?
|
| Deoxyguanosine | 1 | 2002 | 28 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 177 | 0.040 |
Why?
|
| Cognition Disorders | 2 | 2017 | 239 | 0.040 |
Why?
|
| Indium | 1 | 2021 | 4 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2018 | 2208 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 222 | 0.040 |
Why?
|
| Protein Structure, Secondary | 2 | 2012 | 340 | 0.040 |
Why?
|
| Chromosomes | 1 | 2021 | 91 | 0.040 |
Why?
|
| Drug Approval | 1 | 2022 | 69 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2016 | 520 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 40 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 1384 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1646 | 0.040 |
Why?
|
| Herbivory | 1 | 2021 | 35 | 0.040 |
Why?
|
| RNA, Ribosomal | 2 | 2011 | 66 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 532 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 1014 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 164 | 0.040 |
Why?
|
| Amino Acids | 1 | 2021 | 247 | 0.040 |
Why?
|
| Genetic Testing | 2 | 2018 | 594 | 0.040 |
Why?
|
| Mentors | 1 | 2021 | 103 | 0.040 |
Why?
|
| Gabon | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cameroon | 1 | 2019 | 19 | 0.040 |
Why?
|
| Asthma | 1 | 2008 | 1078 | 0.040 |
Why?
|
| Forensic Genetics | 1 | 2019 | 1 | 0.040 |
Why?
|
| Forensic Anthropology | 1 | 2019 | 2 | 0.040 |
Why?
|
| Body Remains | 1 | 2019 | 4 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2021 | 345 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2011 | 78 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 889 | 0.040 |
Why?
|
| Comorbidity | 1 | 2023 | 1032 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2019 | 65 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 3605 | 0.040 |
Why?
|
| Biopsy | 1 | 2003 | 1224 | 0.040 |
Why?
|
| Calcium | 1 | 2024 | 1196 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2011 | 780 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2019 | 44 | 0.040 |
Why?
|
| Veterans Health | 1 | 2019 | 24 | 0.040 |
Why?
|
| Huntington Disease | 2 | 2011 | 36 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 1944 | 0.040 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2018 | 4 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 39 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2018 | 22 | 0.040 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2018 | 39 | 0.040 |
Why?
|
| Acylation | 1 | 2018 | 68 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2019 | 164 | 0.030 |
Why?
|
| Synchrotrons | 1 | 2018 | 33 | 0.030 |
Why?
|
| Papio hamadryas | 1 | 2018 | 1 | 0.030 |
Why?
|
| Social Responsibility | 1 | 2008 | 53 | 0.030 |
Why?
|
| X-Rays | 1 | 2018 | 139 | 0.030 |
Why?
|
| Receptors, Somatotropin | 1 | 2018 | 19 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2018 | 25 | 0.030 |
Why?
|
| Peptides | 1 | 2021 | 669 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2018 | 69 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2013 | 743 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2017 | 15 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 2018 | 117 | 0.030 |
Why?
|
| Doxycycline | 1 | 2018 | 40 | 0.030 |
Why?
|
| Callithrix | 1 | 2017 | 17 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2018 | 70 | 0.030 |
Why?
|
| Borneo | 1 | 2017 | 1 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 304 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 95 | 0.030 |
Why?
|
| Population Dynamics | 1 | 2018 | 149 | 0.030 |
Why?
|
| Policy Making | 1 | 2007 | 64 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2009 | 276 | 0.030 |
Why?
|
| Human Migration | 1 | 2017 | 31 | 0.030 |
Why?
|
| Leucine | 1 | 2017 | 57 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2015 | 730 | 0.030 |
Why?
|
| Bibliometrics | 1 | 2007 | 49 | 0.030 |
Why?
|
| Proline | 1 | 2017 | 51 | 0.030 |
Why?
|
| Phylogeography | 1 | 2017 | 60 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2018 | 120 | 0.030 |
Why?
|
| Climate | 1 | 2017 | 63 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Benzo(a)pyrene | 1 | 2016 | 6 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2016 | 12 | 0.030 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2016 | 13 | 0.030 |
Why?
|
| North America | 1 | 2017 | 210 | 0.030 |
Why?
|
| Vegetables | 1 | 2017 | 50 | 0.030 |
Why?
|
| Speech | 1 | 2017 | 91 | 0.030 |
Why?
|
| Fruit | 1 | 2017 | 81 | 0.030 |
Why?
|
| Opossums | 1 | 2016 | 6 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2019 | 448 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 370 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 145 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 187 | 0.030 |
Why?
|
| Arctic Regions | 1 | 2015 | 11 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2016 | 76 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 17 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2016 | 97 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2015 | 16 | 0.030 |
Why?
|
| Elephants | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 397 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 108 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 140 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 22 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 50 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 81 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 85 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 401 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2037 | 0.030 |
Why?
|
| Africa, Southern | 1 | 2014 | 3 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 679 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 487 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 128 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 564 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 889 | 0.030 |
Why?
|
| Epigenomics | 1 | 2015 | 111 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 198 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 161 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2015 | 131 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 92 | 0.030 |
Why?
|
| Luteinizing Hormone | 1 | 2015 | 146 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 175 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 26 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 224 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2015 | 125 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2008 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 147 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 285 | 0.030 |
Why?
|
| Demography | 1 | 2014 | 193 | 0.030 |
Why?
|
| Africa, Western | 1 | 2014 | 12 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 375 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2019 | 484 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2014 | 50 | 0.030 |
Why?
|
| Cooking | 1 | 2014 | 71 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1283 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 182 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2013 | 95 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 508 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 721 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 762 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 435 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 176 | 0.020 |
Why?
|
| Central Nervous System Diseases | 1 | 2012 | 36 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 872 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 77 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 370 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 34 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2011 | 41 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 164 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2011 | 61 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2012 | 302 | 0.020 |
Why?
|
| Dynamins | 1 | 2011 | 49 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2580 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2010 | 31 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 310 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 178 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1781 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 193 | 0.020 |
Why?
|
| Algorithms | 2 | 2011 | 2001 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2018 | 1717 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2010 | 39 | 0.020 |
Why?
|
| Culture | 1 | 2010 | 57 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 3246 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2010 | 52 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 319 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 388 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 72 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2666 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 426 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 384 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 2 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Autophagy | 1 | 2011 | 177 | 0.020 |
Why?
|
| Maze Learning | 1 | 2009 | 33 | 0.020 |
Why?
|
| Presenilins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2008 | 25 | 0.020 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2008 | 1 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2008 | 19 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 403 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2008 | 161 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2008 | 89 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2529 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 3623 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 311 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2012 | 552 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 448 | 0.020 |
Why?
|
| Sp Transcription Factors | 1 | 2007 | 1 | 0.020 |
Why?
|
| Extraembryonic Membranes | 1 | 2007 | 8 | 0.020 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2007 | 7 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 129 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3329 | 0.020 |
Why?
|
| Euchromatin | 1 | 2006 | 6 | 0.020 |
Why?
|
| Achilles Tendon | 1 | 2007 | 17 | 0.020 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2006 | 6 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2006 | 59 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2007 | 62 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 4000 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 215 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1836 | 0.020 |
Why?
|
| Vitamin E | 1 | 2006 | 34 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 177 | 0.020 |
Why?
|
| Huntingtin Protein | 1 | 2006 | 12 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2006 | 74 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1133 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 124 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2007 | 295 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 438 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1790 | 0.010 |
Why?
|
| Autistic Disorder | 1 | 2007 | 155 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 237 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 254 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2006 | 102 | 0.010 |
Why?
|
| Apoptosis | 1 | 2012 | 1752 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 235 | 0.010 |
Why?
|
| Vaccination | 1 | 2008 | 323 | 0.010 |
Why?
|
| Benzenesulfonates | 1 | 2005 | 49 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 483 | 0.010 |
Why?
|
| Histones | 1 | 2007 | 370 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 1302 | 0.010 |
Why?
|
| Cyclin B1 | 1 | 2004 | 16 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 41 | 0.010 |
Why?
|
| G2 Phase | 1 | 2004 | 32 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 403 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 193 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 76 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 663 | 0.010 |
Why?
|
| Software | 1 | 2008 | 693 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 152 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 608 | 0.010 |
Why?
|
| Cytochromes | 1 | 2002 | 60 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 10947 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 668 | 0.010 |
Why?
|
| Proteins | 1 | 2007 | 804 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 373 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2783 | 0.010 |
Why?
|